Madrigal Pharma (MDGL) Tops Q1 EPS by 94c
Tweet
Share
E-mailGet Alerts MDGL Hot Sheet
Join SI Premium – FREE
Madrigal Pharma (NASDAQ: MDGL) reported Q1 EPS of ($3.25), $0.94 better than the analyst estimate of ($4.19). Revenue for the quarter came in at $311.34 million versus the consensus estimate of $301.29 million.
For earnings history and earnings-related data on Madrigal Pharma (MDGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Canaan Inc. (CAN) PT Lowered to $2 at BTIG
- Argo Graphene raises private placement target to $1.5M
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
